The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...

Bayer announced the FDA approved finerenone, a nonsteroidal selective mineralocorticoid receptor antagonist, for the ...

Star Hospitals in Hyderabad has launched a dedicated Heart Failure Clinic to address the rising cardiac health crisis. The ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Scientists have discovered that four health habits — which include sleep quality and nicotine use — were the most important ...

For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, mortality, and HF hospitalization.

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

No significant difference in mortality was observed at 96 hours among children with severe acute malnutrition and ...

Many women with serious underlying medical conditions like heart disease need birth control that won't make their conditions ...

Even small amounts of processed meats are associated with a greater risk of type 2 diabetes, heart disease, and cancer, a new ...

SGLT2 inhibitors reduced heart failure events and cardiovascular death in patients with heart failure, type 2 diabetes, chronic kidney disease, and atherosclerotic cardiovascular disease. These ...